Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?
<p><strong></strong><strong>Introduction:</strong> Hairy cell leukemia is a rare B-cell lymph proliferation with long-term survivals, in general. Although therapeutic possibilities have progressed over time, many patients have recurrences and the disease can become resi...
Na minha lista:
Autor principal: | Romeo-Gabriel Mihaila (Author) |
---|---|
Formato: | Livro |
Publicado em: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2015-08-14.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registos relacionados
-
Genetics of hairy cell leukemia
Por: Jorge J. Nieva
Publicado em: (2011) -
Genetics of hairy cell leukemia
Por: Jorge J. Nieva
Publicado em: (2011) -
Cost-effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain
Por: Ricardo Ginestal, et al.
Publicado em: (2023) -
BRAF mutation in hairy cell leukemia
Por: Ahmad Ahmadzadeh, et al.
Publicado em: (2014) -
Hairy cell leukemia: An unusual morphology
Por: Sharma Anjali, et al.
Publicado em: (2010)